Breast Cancer | Topics

Patients With Postmenopausal HR+/HER2– Advanced Breast Cancer Experience Notable OS Benefit With Ribociclib/Letrozole Combo
September 19, 2021

Data from the phase 3 MONALEESA-2 trial demonstrate significant benefit of frontline ribociclib (Kisqali) added to letrozole for hormone receptor–positive, HER2-negative advanced breast cancer

[vic]-Trastuzumab Duocarmazine Improved Survival For HER2-Positive Metastatic Breast Cancer
September 19, 2021

Treatment [vic]-trastuzumab duocarmazine improved progression-free survival for patients with pretreated, metastatic HER2-positive breast cancer when compared with physician’s choice chemotherapy.

Adjuvant/Neoadjuvant Chemotherapy Is Not Associated With Complications or Patient-Reported Outcomes Among Breast Cancer Survivors
September 15, 2021

Patients undergoing implant-based or autologous reconstruction and received adjuvant or neoadjuvant chemotherapy did not have an association with likelihood of complications compared with those who did not undergo chemotherapy.